Research
Hormonal
Tirzepatide can achieve weight loss of up to 22.5% at the highest doses.
Tirzepatide represents a potent option for significant weight loss in obese patients.
StrongSupportsmedium confidence
Tirzepatide (un agonista dual del receptor GLP-1/GIP) consigue una pérdida de peso de hasta un 22,5% en las dosis más altas.
Why this rating
The claim is based on clinical data regarding tirzepatide's efficacy.
Source
Weight management treatment in obesity
Miguel A. Rubio et al. · Medicina Clínica (English Edition) · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →